Molecular Pathway of Psoralidin-Induced Apoptosis in HepG2 Cell Line
Back to article page
Original Article|Updated:2021-08-27
|
Molecular Pathway of Psoralidin-Induced Apoptosis in HepG2 Cell Line
Molecular Pathway of Psoralidin-Induced Apoptosis in HepG2 Cell Line
Chinese Journal of Integrative Medicine2019年25卷第10期 页码:757-762
Affiliations:
1.School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin (300193), China
2.Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin (300193), China
3.Department of pharmacy, Gansu Provincial Hospital, Lanzhou (731600), China
4.Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin (300193), China
5.College of Pharmacy, Henan University, Kaifeng, Henan Province (475004), China
Author bio:
Correspondence to: Prof. ZHOU Kun, Tel: 86-22-59596164, Fax: 86-22-27386453, E-mail: z.k.ken@263.net
Funds:
the National Natural Science Foundation of China(81202991);Tianjin City Application Basis, Cutting-edge Technology Research Program (Tianjin Municipal Science and Technology Commission)(13JCYBJC38500)
Bin YU, An-hong WANG, Kun ZHOU, 等. Molecular Pathway of Psoralidin-Induced Apoptosis in HepG2 Cell Line[J]. Chinese Journal of Integrative Medicine, 2019,25(10):757-762.
Bin YU, An-hong WANG, Kun ZHOU, et al. Molecular Pathway of Psoralidin-Induced Apoptosis in HepG2 Cell Line[J]. Chinese Journal of Integrative Medicine, 2019,25(10):757-762.
Bin YU, An-hong WANG, Kun ZHOU, 等. Molecular Pathway of Psoralidin-Induced Apoptosis in HepG2 Cell Line[J]. Chinese Journal of Integrative Medicine, 2019,25(10):757-762. DOI: 10.1007/s11655-016-2251-5.
Bin YU, An-hong WANG, Kun ZHOU, et al. Molecular Pathway of Psoralidin-Induced Apoptosis in HepG2 Cell Line[J]. Chinese Journal of Integrative Medicine, 2019,25(10):757-762. DOI: 10.1007/s11655-016-2251-5.
Molecular Pathway of Psoralidin-Induced Apoptosis in HepG2 Cell Line
摘要
Abstract
Objective:
2
To test the role of psoralidin in human liver cancer HepG2 cells in vitro.
Methods:
2
Cell viability was assessed by methylthiazolyldiphenyl-tetrazolum bromide assay and apoptotic cells were labeled by annexin V then sorted by flow cytometry. Protein expressions of caspase-3
caspase-8
caspase-9
Bax
Bid
Bcl-2
Bcl-xL and p53 were examined by western blot while activity of caspase-3
-8 and -9 were also determined.
Results:
2
Psoralidin reduces cell viability greatly in a time dependent manner (64%
40%
21%
12% at 2
6
24 and 48 h treatment with 64 μmol/L psoralidin respectively) and up-regulates activities of caspase-3
-8 and -9 in a concentration dependent manner (between 4 to 64 μmol/L). Psoralidin also increases the expression of pro-apoptosis genes Bax
Bid and p53 while decreases the expression of pro-survival genes Bcl-2 and Bcl-xL
both in a concentration dependent manner between 4 and 64 μmol/L (
P
<
0.05 at 16 and 64 μmol/L). Caspase-3 inhibitor (Ac-DEVD-CHO at concentrations between 10 to 20 μmol/L)
p53 inhibitor (pifithrin-α at 5 μmol/L) and cyclosporin A can attenuate the apoptotic effect of psoralidin.
Conclusion:
2
The cytotoxic role of psoralidin might work through both intrinsic and extrinsic apoptotic pathway.
关键词
Keywords
psoralidinapoptosisHepG2mitochondriap53cyclosporin A